Alpha-Beta Gliadin IgA

When gluten irritates the gut in a gluten-sensitive person, the immune system often starts making antibodies against it, and this test measures one of them. A raised result is a clue that your body is reacting to gluten, most importantly as a possible sign of celiac disease.

This is an older celiac marker, though, and it is no longer the first test most specialists reach for. Knowing what it can and cannot tell you is the difference between a useful clue and a false alarm.

What This Antibody Actually Measures

This test measures AGA (anti-gliadin antibodies) of the IgA (immunoglobulin A) class that your body makes against gliadin, one of the main protein groups inside wheat gluten. The conventional test uses a crude gliadin extract that contains several fractions, including the alpha and beta gliadins. It measures a product of your own immune system, not a piece of wheat floating in your blood.

IgA antibodies are mostly made by immune cells in the lining of the gut, so this marker reflects a reaction happening at the gut wall where gluten is first encountered. That is why it tends to rise in conditions where gluten inflames the intestine rather than as a general marker of overall health.

Why It Points to Celiac Disease

Celiac disease is a condition where eating gluten triggers immune damage to the small intestine in genetically prone people. Blood gliadin IgA is one of the antibodies that rises in untreated celiac disease, which is the main reason the test exists. In studies, people with untreated celiac disease had significantly higher blood gliadin IgA than people without the disease.

How well the test performs depends heavily on which version of the assay is used and who is being tested. The table below shows the range.

Source: Rashtak et al. 2008; Sugai et al. 2006; Verma et al. 2018.

What this means for you: a positive result should prompt confirmation rather than conclusion. On its own, this marker misses some cases and flags some people who do not have celiac disease, so it works best as one piece of a larger celiac workup.

The IgA Deficiency Blind Spot

Some people cannot make normal amounts of IgA, a condition called selective IgA deficiency, and it is several times more common in people with celiac disease than in the general population, affecting roughly 2 to 4% of celiac patients. Because this test measures an IgA antibody, a person with IgA deficiency can have celiac disease and still show a low or negative result.

That is why a total IgA level is usually measured alongside it. If your total IgA is low, IgG-based antibody tests are used instead, because the IgA versions cannot be trusted to catch the disease.

A Different Signal in Schizophrenia

Blood gliadin IgA has also been studied outside the gut. In one case-control study, people with schizophrenia were about 1.7 times as likely to test positive for IgA antibodies against gliadin as people without it (27.1% versus 17.8%), and in that particular cohort the link was stronger in women, at roughly 2.4 times as likely. Most other work in this area has focused on IgG rather than IgA antibodies, so this specific pattern comes from a single study.

This is an association between groups, not a way to predict or diagnose anything in an individual, and the effect was small. It also did not look like celiac disease, because the more celiac-specific antibodies were not elevated in these patients, suggesting a different kind of immune response rather than hidden celiac disease.

Positive Without Disease

The single most important thing to understand about this test is that a positive result does not equal a diagnosis. Anti-gliadin antibodies show up in roughly 10% of the general population, and in one case-control study these incidental positives came with no measurable differences in memory, thinking, or brain scans.

The cleanest way to hold this is to treat the marker as a reactivity indicator, not a disease switch. A raised level tells you the immune system is engaging with gluten; whether that reflects celiac disease, a distinct immune pattern like the one seen in some schizophrenia cases, or a harmless finding depends entirely on the clinical context and on more specific tests.

When a Single Reading Can Fool You

A few situations can make one reading misleading.

• Already avoiding gluten: this antibody falls once gluten is removed, so testing on a gluten-free or low-gluten diet can produce a falsely reassuring result. You need to be eating gluten for the test to mean anything.
• IgA deficiency: if your body makes little IgA, this test can read low even with real celiac disease, which is why total IgA is checked alongside it.
• Assay confusion: older native gliadin antibody tests and newer deamidated gliadin peptide tests are often both labeled as gliadin antibodies but are different assays with different accuracy, so results are not interchangeable across labs.
• Non-celiac positives: because a meaningful share of healthy people are positive, an isolated raised value without symptoms or confirmatory testing can point you in the wrong direction.

Why Tracking Beats a Single Test

For a first diagnostic question, one reading taken while you are eating gluten, combined with confirmatory testing, is what matters. Trending becomes useful afterward, if gluten sensitivity is confirmed and you want to see whether your immune reactivity is settling down.

In treated celiac disease, this antibody tends to be present while gluten is being eaten and declines after gluten is removed, which is why it has historically been used to gauge dietary adherence. Most celiac antibodies fall within the first year and normalize by 24 to 36 months. A sensible rhythm is a baseline while still on gluten, a follow-up a few months after a diet change, and yearly checks after that, though the exact early timepoint is not universally standardized. One caveat: a falling antibody reflects reduced gluten exposure and immune activity, but it does not by itself prove the gut lining has fully healed.

What an Unexpected Result Should Make You Do

If this antibody comes back raised, the next step is confirmation, not self-diagnosis. Order or ask for tissue transglutaminase IgA and total IgA, and often endomysial IgA, which together are more specific for celiac disease. If those support the picture or your symptoms persist, a gastroenterologist can decide whether a duodenal biopsy is warranted.

One practical rule matters most: do not start a gluten-free diet before this workup is complete. Removing gluten early lowers all of these antibodies and can heal the gut enough to hide the diagnosis, leaving you without a clear answer. If you are already gluten-free, tell your clinician, because your results cannot rule celiac disease in or out until gluten is reintroduced under guidance.